An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options. The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor. Technavio’s analysts forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Technavio's report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
Market driver - Demand for personalized medicines - For a full, detailed list, view our report
Market challenge - High cost of developing companion diagnostics - For a full, detailed list, view our report
Market trend - Demand for personalized medicines - For a full, detailed list, view our report
Key questions answered in this report - What will the market size be in 2020 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Our reports have been used by over 10K customers, including:
The Global Cancer Diagnostics Partnering Terms and Agreements 2014-2020 report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones...
Breast Cancer Diagnostics Market Research Report by Type (Biopsy, Blood Tests, Genomic Tests, and Imaging), by Technique (Imaging, Molecular Testing, and Tissue Biopsy Tests), by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Breast Cancer Diagnostics Market is expected to grow from...
Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Analyzers pipeline products with comparative analysis of...
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Point-of-Care (POC) Analyzers pipeline products with comparative...
Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products...
Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Lung Cancer Diagnostic Tests pipeline products with comparative analysis...
Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Rapid Tests & POC pipeline products...
Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Therapeutic Drug Monitoring Tests pipeline products with...
2020-2025 U.K. Molecular Diagnostics Database: Market Shares and Forecasts for 100 Tests--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing This database provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics,...
The Digital PCR market is projected to register a CAGR of nearly 17.8% over the forecast period. The major factor attributing to the growth of the market is the rising diagnostics and screening tests of diseases like cancer, hereditary, and infectious diseases, and the growing demand for parental testing and gene study. As per GLOBOCAN, the...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.